SANTEN PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 4536/N for the last quarter is 9.27 B MXN, and it's 8.27% higher compared to the previous quarter. The net income of Q3 23 is 881.98 M MXN.